Multiple sclerosis, Lancet. Apr, vol.6359, issue.9313, pp.1221-1252, 2002. ,
Multiple sclerosis. Lancet, pp.1502-1519, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT, Neurology, vol.38, issue.2, pp.180-185, 1988. ,
DOI : 10.1212/WNL.38.2.180
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-69, 1997. ,
DOI : 10.1093/brain/120.11.2059
Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters., Radiology, vol.195, issue.3, 1995. ,
DOI : 10.1148/radiology.195.3.7754002
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness, Journal of Neuroimmunology, vol.180, issue.1-2, pp.17-28, 2006. ,
DOI : 10.1016/j.jneuroim.2006.07.006
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination, Annals of Neurology, vol.143, issue.6, pp.707-724, 2000. ,
DOI : 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
The Immunopathology of Multiple Sclerosis: An Overview, Brain Pathology, vol.60, issue.2, pp.210-218, 2007. ,
DOI : 10.1016/S0896-6273(03)00326-X
THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY, Brain, vol.112, issue.1, pp.133-179, 1989. ,
DOI : 10.1093/brain/112.1.133
Relapses and Progression of Disability in Multiple Sclerosis, New England Journal of Medicine, vol.343, issue.20, pp.1430-1438, 2000. ,
DOI : 10.1056/NEJM200011163432001
Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis, Archives of Neurology, vol.63, issue.12, pp.1686-91, 2006. ,
DOI : 10.1001/archneur.63.12.1686
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis, New England Journal of Medicine, vol.346, issue.3, pp.158-64, 2002. ,
DOI : 10.1056/NEJMoa011341
THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY, Brain, vol.112, issue.6, pp.1419-1447, 1989. ,
DOI : 10.1093/brain/112.6.1419
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, pp.770-82, 2003. ,
DOI : 10.1093/brain/awg081
URL : https://hal.archives-ouvertes.fr/hal-00427394
Prognostic indicators for long-term disability in multiple sclerosis patients, Journal of the Neurological Sciences, vol.324, issue.1-2, pp.29-33, 2013. ,
DOI : 10.1016/j.jns.2012.09.020
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983. ,
DOI : 10.1212/WNL.33.11.1444
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicenter, double-blind, placebo-controlled trial, Neurology, vol.45, issue.7, pp.1268-76, 1995. ,
DOI : 10.1212/WNL.45.7.1268
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.354, issue.9, pp.899-910, 2006. ,
DOI : 10.1056/NEJMoa044397
A placebocontrolled trial of oral fingolimod in relapsing multiple sclerosis, N Engl J Med. 2010 Feb, vol.4362, issue.5, pp.387-401 ,
URL : https://hal.archives-ouvertes.fr/hal-00617764
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis, Cochrane Database Syst Rev, issue.4, p.1331, 2000. ,
The diagnostic criteria for multiple sclerosis: From Charcot to McDonald, Multiple Sclerosis and Related Disorders, vol.1, issue.1, pp.9-14 ,
DOI : 10.1016/j.msard.2011.08.002
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS, Annals of the New York Academy of Sciences, vol.43, issue.6, pp.552-68, 1965. ,
DOI : 10.1111/j.1749-6632.1965.tb20235.x
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-258, 1983. ,
DOI : 10.1002/ana.410130302
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.121-128, 2001. ,
DOI : 10.1002/ana.1032
New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode, Neurology, vol.60, issue.1, pp.27-30, 2003. ,
DOI : 10.1212/WNL.60.1.27
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, 2005. ,
DOI : 10.1002/ana.20703
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study, The Lancet Neurology, vol.6, issue.8, pp.677-86, 2007. ,
DOI : 10.1016/S1474-4422(07)70176-X
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, 2011. ,
DOI : 10.1002/ana.22366
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes, Multiple Sclerosis Journal, vol.19, issue.6, pp.714-720, 2013. ,
DOI : 10.1002/ana.22247
The changing demographic pattern of multiple sclerosis epidemiology, The Lancet Neurology, vol.9, issue.5, pp.520-552 ,
DOI : 10.1016/S1474-4422(10)70064-8
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis, PLoS ONE, vol.76, issue.3, p.48078, 2012. ,
DOI : 10.1371/journal.pone.0048078.t003
A REASSESSMENT OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS, Acta Neurologica Scandinavica, vol.9, issue.Suppl. 147, pp.110-146, 1975. ,
DOI : 10.1111/j.1600-0404.1975.tb01364.x
Why does the north???south gradient of incidence of multiple sclerosis seem to have disappeared on the Northern hemisphere?, Journal of the Neurological Sciences, vol.311, issue.1-2, pp.58-63, 2011. ,
DOI : 10.1016/j.jns.2011.09.003
Geographic variations of multiple sclerosis in France, Brain, vol.133, issue.7, pp.1889-99, 2010. ,
DOI : 10.1093/brain/awq134
Association of UV radiation with multiple sclerosis prevalence and sex ratio in France, Neurology, vol.76, issue.5, pp.425-456, 2011. ,
DOI : 10.1212/WNL.0b013e31820a0a9f
URL : https://hal.archives-ouvertes.fr/hal-00567871
Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies., Journal of Neurology, Neurosurgery & Psychiatry, vol.50, issue.3, pp.327-359, 1987. ,
DOI : 10.1136/jnnp.50.3.327
Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.63, issue.5, pp.565-573, 1997. ,
DOI : 10.1136/jnnp.63.5.565
The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia, Brain, vol.123, issue.5, pp.968-74, 2000. ,
DOI : 10.1093/brain/123.5.968
Migration and multiple sclerosis: The French West Indies experience, Journal of the Neurological Sciences, vol.262, issue.1-2, pp.117-138, 2007. ,
DOI : 10.1016/j.jns.2007.06.044
Clinical features of multiple sclerosis in a genetically homogeneous tropical population, Multiple Sclerosis Journal, vol.6, issue.4, pp.227-236, 2001. ,
DOI : 10.1177/135245850100700403
Environmental risk factors for multiple sclerosis. Part I: The role of infection, Annals of Neurology, vol.66, issue.suppl, pp.288-99, 2007. ,
DOI : 10.1002/ana.21117
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors, Annals of Neurology, vol.108, issue.6, pp.504-517, 2007. ,
DOI : 10.1002/ana.21141
Genetic epidemiology of multiple sclerosis., Journal of Neurology, Neurosurgery & Psychiatry, vol.62, issue.6, pp.553-61, 1997. ,
DOI : 10.1136/jnnp.62.6.553
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci, Annals of Neurology, vol.10, issue.6, pp.897-912, 2011. ,
DOI : 10.1002/ana.22609
Role of return migration in the emergence of multiple sclerosis in the French West Indies, Brain, vol.128, issue.12, pp.2899-910, 2005. ,
DOI : 10.1093/brain/awh624
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases, Annals of Neurology, vol.12, issue.suppl, pp.123-153, 1987. ,
DOI : 10.1002/ana.410210204
Recurrent Optic Neuromyelitis with Endocrinopathies: A New Syndrome, Neurology, vol.48, issue.1, pp.58-64, 1997. ,
DOI : 10.1212/WNL.48.1.58
Multiple sclerosis in the black population]. Bull Société Pathol Exot, pp.428-460, 1990. ,
Environmental changes and epidemiology of multiple sclerosis in the French West Indies, Journal of the Neurological Sciences, vol.286, issue.1-2, pp.58-61, 2009. ,
DOI : 10.1016/j.jns.2009.04.039
Multiple sclerosis and solar exposure before the age of 15 years: case???control study in Cuba, Martinique and Sicily, Multiple Sclerosis Journal, vol.117, issue.8, pp.899-908, 2010. ,
DOI : 10.1093/brain/123.6.1102
URL : https://hal.archives-ouvertes.fr/hal-00606425
The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, vol.53, issue.5, pp.1107-1121, 1999. ,
DOI : 10.1212/WNL.53.5.1107
Neuromyelitis optica: Clinical predictors of a relapsing course and survival, Neurology, vol.60, issue.5, pp.848-53, 2003. ,
DOI : 10.1212/01.WNL.0000049912.02954.2C
A secondary progressive clinical course is uncommon in neuromyelitis optica, Neurology, vol.68, issue.8, pp.603-608, 2007. ,
DOI : 10.1212/01.wnl.0000254502.87233.9a
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica, Journal of Neurology, vol.251, issue.1, pp.47-52, 2004. ,
DOI : 10.1007/s00415-004-0271-0
Characteristics of Devic's disease (neuromyelitis optica) in Mexico, Journal of Neurology, vol.66, issue.5, pp.710-715, 2008. ,
DOI : 10.1007/s00415-008-0781-2
Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler, pp.613-622, 2009. ,
Relapsing neuromyelitis optica: long term history and clinical predictors of death, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.10, pp.1162-1166, 2009. ,
DOI : 10.1136/jnnp.2007.143529
Neuromyelitis optica in France: A multicenter study of 125 patients, Neurology, vol.74, issue.9, pp.736-778, 2010. ,
DOI : 10.1212/WNL.0b013e3181d31e35
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.111, issue.Suppl 4, pp.1777-85, 2010. ,
DOI : 10.1007/s00417-010-1344-7
Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica, Neurology, vol.65, issue.9, pp.1479-82, 2005. ,
DOI : 10.1212/01.wnl.0000183151.19351.82
Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.9, pp.1075-1083, 2008. ,
DOI : 10.1136/jnnp.2008.145391
Neuromyelitis optica with hypothalamic involvement. Mult Scler, pp.617-638, 2005. ,
Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.6, pp.679-82, 2009. ,
DOI : 10.1136/jnnp.2008.157693
Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.3, pp.333-337, 2008. ,
DOI : 10.1136/jnnp.2007.135228
Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody, J Neurol, 2009. ,
Clinical spectrum of CNS aquaporin-4 autoimmunity, Neurology, vol.78, issue.15, pp.1179-85, 2012. ,
DOI : 10.1212/WNL.0b013e31824f8069
Pain in neuromyelitis optica and its effect on quality of life: A cross-sectional study, Neurology, vol.77, issue.7, 2011. ,
DOI : 10.1212/WNL.0b013e318229e694
Brain Abnormalities in Neuromyelitis Optica, Archives of Neurology, vol.63, issue.3, p.390, 2006. ,
DOI : 10.1001/archneur.63.3.390
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression, Archives of Neurology, vol.63, issue.7, p.964, 2006. ,
DOI : 10.1001/archneur.63.7.964
CNS aquaporin-4 autoimmunity in children, Neurology, vol.71, issue.2, pp.93-100, 2008. ,
DOI : 10.1212/01.wnl.0000314832.24682.c6
La neuromy??lite optique r??mittente: donn??es neuroradiologiques, Revue Neurologique, vol.162, issue.5, pp.595-602, 2006. ,
DOI : 10.1016/S0035-3787(06)75053-6
Optic neuritis in neuromyelitis optica, Progress in Retinal and Eye Research, vol.36, pp.159-71, 2013. ,
DOI : 10.1016/j.preteyeres.2013.03.001
Brain magnetic resonance imaging abnormalities in neuromyelitis optica, Acta Neurologica Scandinavica, vol.13, issue.4, pp.218-243, 2008. ,
DOI : 10.1111/j.1600-0404.2008.01012.x
Devic's neuromyelitis optica: A clinicopathological study of 8 patients, Annals of Neurology, vol.41, issue.2, pp.162-170, 1993. ,
DOI : 10.1002/ana.410340211
MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica, Neurology, vol.53, issue.8, pp.1705-1705, 1999. ,
DOI : 10.1212/WNL.53.8.1705
MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis, Journal of Neuroradiology, vol.36, issue.4, pp.199-205, 2009. ,
DOI : 10.1016/j.neurad.2008.12.008
Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study, European Radiology, vol.60, issue.Pt 11, pp.2535-2578, 2009. ,
DOI : 10.1007/s00330-009-1425-3
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica, Brain, vol.125, issue.7, pp.1450-61, 2002. ,
DOI : 10.1093/brain/awf151
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica, Acta Neuropathologica, vol.66, issue.6, pp.815-842, 2013. ,
DOI : 10.1007/s00401-013-1116-7
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis, The Lancet, vol.364, issue.9451, pp.2106-2118, 2004. ,
DOI : 10.1016/S0140-6736(04)17551-X
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel, The Journal of Experimental Medicine, vol.43, issue.4, pp.473-480, 2005. ,
DOI : 10.1523/JNEUROSCI.1485-04.2004
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis, Brain, vol.130, issue.5, pp.1224-1258, 2007. ,
DOI : 10.1093/brain/awm047
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis, Brain, vol.130, issue.5, pp.1194-205, 2007. ,
DOI : 10.1093/brain/awl371
Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter, Acta Neuropathologica, vol.109, issue.2, pp.187-94, 2007. ,
DOI : 10.1007/s00401-006-0169-2
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica, Nature Clinical Practice Neurology, vol.68, issue.4, pp.202-216, 2008. ,
DOI : 10.1038/ncpneuro0764
Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study, Neurology, vol.75, issue.3, pp.208-224, 2010. ,
DOI : 10.1212/WNL.0b013e3181e2414b
Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica, Autoimmunity Reviews, vol.9, issue.2, pp.132-137, 2009. ,
DOI : 10.1016/j.autrev.2009.04.004
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica, Brain, vol.131, issue.11, 2008. ,
DOI : 10.1093/brain/awn240
NMO-IgG in the diagnosis of neuromyelitis optica, Neurology, vol.68, issue.13, pp.1076-1083, 2007. ,
DOI : 10.1212/01.wnl.0000256822.01222.bd
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler Houndmills Basingstoke Engl, pp.1153-63, 2009. ,
Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.9, pp.1073-1078, 2006. ,
DOI : 10.1136/jnnp.2005.080390
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese, Brain, vol.130, issue.5, pp.1206-1229, 2007. ,
DOI : 10.1093/brain/awm027
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies, Multiple Sclerosis Journal, vol.201, issue.7, pp.828-861, 2009. ,
DOI : 10.1001/archneur.63.3.390
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica, Neurology, vol.81, issue.14, pp.1197-2004, 2013. ,
DOI : 10.1212/WNL.0b013e3182a6cb5c
Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations, Multiple Sclerosis, vol.10, issue.1, pp.2-4, 2004. ,
DOI : 10.1191/1352458504ms988oa
CSF ANALYSIS AND THE DIAGNOSIS OF NEUROMYELITIS OPTICA, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.11, p.2, 2013. ,
DOI : 10.1136/jnnp-2013-306573.21
Neuromyelitis Optica and Non???Organ-Specific Autoimmunity, Archives of Neurology, vol.65, issue.1, pp.78-83, 2008. ,
DOI : 10.1001/archneurol.2007.17
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve, pp.87-90, 2009. ,
A Benign Form of Neuromyelitis Optica, Archives of Neurology, vol.68, issue.7, pp.918-942, 2011. ,
DOI : 10.1001/archneurol.2011.127
Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine, Neurology, vol.51, issue.4, pp.1219-1239, 1998. ,
DOI : 10.1212/WNL.51.4.1219
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil, Archives of Neurology, vol.66, issue.9, p.1128, 2009. ,
DOI : 10.1001/archneurol.2009.175
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica<alt-title>Mitoxantrone for Highly Relapsing Neuromyelitis Optica</alt-title> Arch Neurol, p.473, 2011. ,
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study, Journal of Neurology, Neurosurgery & Psychiatry, vol.84, issue.5, pp.511-517, 2012. ,
DOI : 10.1136/jnnp-2012-303121
An open label study of the effects of rituximab in neuromyelitis optica, Neurology, vol.64, issue.7, pp.1270-1272, 2005. ,
DOI : 10.1212/01.WNL.0000159399.81861.D5
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients, Arch Neurol, vol.65, issue.11, p.1443, 2008. ,
Impact of rituximab on relapse rate and disability in neuromyelitis optica, Multiple Sclerosis Journal, vol.17, issue.10, pp.1225-1255, 2011. ,
DOI : 10.1177/1352458511404586
Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years, Archives of Neurology, vol.68, issue.11, pp.1412-1432, 2011. ,
DOI : 10.1001/archneurol.2011.154
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler, pp.256-265, 2007. ,
Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis, Journal of Neurology, vol.66, issue.2, pp.305-312, 2007. ,
DOI : 10.1007/s00415-007-0730-5
Interferon Beta Treatment in Neuromyelitis Optica, Archives of Neurology, vol.67, issue.8, pp.1016-1023, 2010. ,
DOI : 10.1001/archneurol.2010.188
Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis, European Journal of Neurology, vol.255, issue.5, pp.672-678, 2010. ,
DOI : 10.1111/j.1468-1331.2009.02897.x
Does natalizumab therapy worsen neuromyelitis optica? Neurology, pp.1065-1071, 2012. ,
DOI : 10.1212/wnl.0b013e31826845fe
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica, Archives of Neurology, vol.69, issue.2, pp.239-284, 2012. ,
DOI : 10.1001/archneurol.2011.216
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy. Mult Scler Houndmills Basingstoke Engl, pp.108-120, 2012. ,
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler Houndmills Basingstoke Engl, pp.113-118, 2012. ,
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler Houndmills Basingstoke Engl, pp.487-92, 2009. ,
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler Houndmills Basingstoke Engl, pp.128-160, 2007. ,
Noteomielite " accompanied by acute amaurosis (1844) An early case of neuromyelitis optica, J Neurol Sci Feb, vol.15313, issue.12, pp.182-186, 2012. ,
Myélite subaiguë compliquée de névrite optique, Bull Med (Paris), vol.8, pp.1033-1034, 1894. ,
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica., Journal of Neurology, Neurosurgery & Psychiatry, vol.60, issue.4, pp.382-389, 1996. ,
DOI : 10.1136/jnnp.60.4.382
Revised diagnostic criteria for neuromyelitis optica, American Journal of Ophthalmology, vol.142, issue.4, pp.1485-1494, 2006. ,
DOI : 10.1016/j.ajo.2006.08.010
The spectrum of neuromyelitis optica, The Lancet Neurology, vol.6, issue.9, pp.805-820, 2007. ,
DOI : 10.1016/S1474-4422(07)70216-8
NMO-IgG predicts the outcome of recurrent optic neuritis, Neurology, vol.70, issue.23, pp.2197-200, 2008. ,
DOI : 10.1212/01.wnl.0000303817.82134.da
Relapsing inflammatory optic neuritis: is it neuromyelitis optica? Neurology, pp.2075-2081, 2008. ,
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study, Multiple Sclerosis Journal, vol.15, issue.6, 2011. ,
DOI : 10.1212/WNL.0b013e3181c1deb9
Multiple sclerosis in the Japanese population, The Lancet Neurology, vol.2, issue.2, pp.117-144, 2003. ,
DOI : 10.1016/S1474-4422(03)00308-9
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis, Neurology, vol.63, issue.11, pp.2039-2084, 2004. ,
DOI : 10.1212/01.WNL.0000145762.60562.5D
Descriptive epidemiology of neuromyelitis optica in the Caribbean basin], Rev Neurol, 2009. ,
Optic Neuritis in African Americans, Archives of Neurology, vol.55, issue.2, pp.186-92, 1998. ,
DOI : 10.1001/archneur.55.2.186
Optic neuromyelitis syndrome in Brazilian patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.73, issue.4, pp.429-464, 2002. ,
DOI : 10.1136/jnnp.73.4.429
Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey, Hong Kong Med J Xianggang Yi Xue Za Zhi Hong Kong Acad Med, vol.8, issue.2, pp.77-80, 2002. ,
A retrospective review of patients with clinically definite multiple sclerosis, pp.204-213, 1998. ,
AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems, Neurology, vol.77, issue.9, pp.827-861, 2011. ,
DOI : 10.1212/WNL.0b013e31822c61b1
Clinical profile of multiple sclerosis in Bengal, Neurol India, vol.47, issue.1, pp.18-21, 1999. ,
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years, Multiple Sclerosis, vol.15, issue.2, pp.159-73, 2009. ,
DOI : 10.1177/1352458508098372
A population-based study of neuromyelitis optica in Caucasians, Neurology, vol.76, issue.18, pp.1589-95, 2011. ,
DOI : 10.1212/WNL.0b013e3182190f74
Familial neuromyelitis optica, Neurology, vol.75, issue.4, pp.310-315, 2010. ,
DOI : 10.1212/WNL.0b013e3181ea9f15
Genetic analysis of aquaporin-4 in neuromyelitis optica, Neurology, vol.77, issue.12, pp.1149-55, 2011. ,
DOI : 10.1212/WNL.0b013e31822f045b
Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler, pp.571-580, 2009. ,
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis, Multiple Sclerosis Journal, vol.16, issue.1, pp.21-30, 2009. ,
DOI : 10.1177/1352458509350741
Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population, Multiple Sclerosis Journal, vol.189, issue.1, pp.24-31, 2011. ,
DOI : 10.1371/journal.pgen.0030150
HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies, Brain, vol.122, issue.9, pp.1689-96, 1999. ,
DOI : 10.1093/brain/122.9.1689
URL : http://doi.org/10.1093/brain/122.9.1689
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders Tissue Antigens, 2009. ,
An epidemiological study of neuromyelitis optica in Cuba, Journal of Neurology, vol.66, issue.1, pp.35-44, 2009. ,
DOI : 10.1007/s00415-009-0009-0
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan, Brain, vol.135, issue.6, pp.1834-1883 ,
DOI : 10.1093/brain/aws109
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, pp.521-526, 2003. ,
Neuromyelitis optica: what it is and what it might be, The Lancet, vol.361, issue.9361, pp.889-90, 2003. ,
DOI : 10.1016/S0140-6736(03)12784-5
The pattern of neurological illness in tropical Africa, Journal of the Neurological Sciences, vol.12, issue.4, pp.417-459, 1971. ,
DOI : 10.1016/0022-510X(71)90110-9
Multiple Sclerosis, American Journal of Physical Medicine & Rehabilitation, vol.82, issue.8, pp.582-90, 2003. ,
DOI : 10.1097/01.PHM.0000078199.99484.E2
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurology, vol.38, issue.12, pp.1822-1827, 1988. ,
DOI : 10.1212/WNL.38.12.1822
Migration modifies disability progression in Afro-Carribean with multiple sclerosis ,
Evaluation of the 2005 McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes, European Journal of Neurology, vol.77, issue.11, pp.1191-1197, 2009. ,
DOI : 10.1111/j.1468-1331.2009.02691.x
Response to Interferon-Beta Treatment in Afro-Caribbeans with Multiple Sclerosis, Multiple Sclerosis International, vol.61, issue.2, p.950126, 2011. ,
DOI : 10.1001/archneurol.2008.47
Response to natalizumab treatment in Afro-Caribbean with multiple sclerosis ,
Response to Interferon Beta-1a Treatment in African American Multiple Sclerosis Patients, Archives of Neurology, vol.62, issue.11, pp.1681-1684, 2005. ,
DOI : 10.1001/archneur.62.11.1681
Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis, Archives of Neurology, vol.68, issue.4, pp.464-472, 2011. ,
DOI : 10.1001/archneurol.2011.45
Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders, Ann Neurol, vol.40, issue.4, pp.569-74, 1996. ,
Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status, Multiple Sclerosis Journal, vol.66, issue.2, pp.147-55, 2010. ,
DOI : 10.1016/S0165-5728(98)00074-5
Genetic and environmental backgrounds responsible for the changes in the phenotype of MS in Japanese subjects, Multiple Sclerosis and Related Disorders, vol.1, issue.4, pp.188-95, 2012. ,
DOI : 10.1016/j.msard.2012.05.003
Loss of Aquaporin-4 in Active Perivascular Lesions in Neuromyelitis Optica: A Case Report, The Tohoku Journal of Experimental Medicine, vol.209, issue.3, 2006. ,
DOI : 10.1620/tjem.209.269
Neuromyelitis optica and opticospinal multiple sclerosis: Mechanisms and pathogenesis, Pathophysiology, vol.18, issue.1, pp.69-79, 2011. ,
DOI : 10.1016/j.pathophys.2010.04.008
Interferon beta-1b is effective in Japanese RRMS patients: A randomized, multicenter study, Neurology, vol.64, issue.4, pp.621-651, 2005. ,
DOI : 10.1212/01.WNL.0000151856.10387.E2
Multiple sclerosis and allied diseases in Japan: Clinical characteristics, Neurology, vol.8, issue.10, pp.756-63, 1958. ,
DOI : 10.1212/WNL.8.10.756
Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Neurology, pp.618-640, 1973. ,
Clinical studies of multiple sclerosis in Japan, Journal of the Neurological Sciences, vol.23, issue.2, pp.215-237, 1974. ,
DOI : 10.1016/0022-510X(74)90224-X
OSMS is NMO, but not MS: proven clinically and pathologically, The Lancet Neurology, vol.5, issue.2, pp.110-111, 2006. ,
DOI : 10.1016/S1474-4422(06)70333-7
Neuromyelitis Optica IgG Serostatus in Fulminant Central Nervous System Inflammatory Demyelinating Disease, Archives of Neurology, vol.66, issue.8, p.964, 2009. ,
DOI : 10.1001/archneurol.2009.152
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients, Journal of Neurology, vol.72, issue.Suppl.1, pp.464-70, 2010. ,
DOI : 10.1007/s00415-010-5780-4
NMO-IgG and Devic's neuromyelitis optica: a French experience, Multiple Sclerosis Journal, vol.59, issue.13, pp.440-445, 2008. ,
DOI : 10.1212/01.wnl.0000216139.44259.74
Distinct features between longitudinally extensive transverse myelitis presenting with and without antiaquaporin 4 antibodies, pp.299-307, 2013. ,
Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis, Archives of Neurology, vol.63, issue.10, p.1398, 2006. ,
DOI : 10.1001/archneur.63.10.1398
Anti-aquaporin 4 antibody in Japanese multiple sclerosis: the presence of optic spinal multiple sclerosis without long spinal cord lesions and anti-aquaporin 4 antibody, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.9, pp.990-992, 2007. ,
DOI : 10.1136/jnnp.2006.114165
Intrathecal pathogenic anti??????aquaporin-4 antibodies in early neuromyelitis optica, Annals of Neurology, vol.102, issue.5, pp.617-646, 2009. ,
DOI : 10.1002/ana.21802
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo, Annals of Neurology, vol.66, issue.5, pp.630-673, 2009. ,
DOI : 10.1002/ana.21837
Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells, Biochemical and Biophysical Research Communications, vol.394, issue.1, pp.205-215, 2010. ,
DOI : 10.1016/j.bbrc.2010.02.157
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice, Brain, vol.133, issue.2, pp.349-61, 2010. ,
DOI : 10.1093/brain/awp309
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid, Journal of Neuroimmunology, vol.254, issue.1-2, pp.76-82, 2013. ,
DOI : 10.1016/j.jneuroim.2012.09.010
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica, Neurology, vol.69, issue.24, pp.2221-2252, 2007. ,
DOI : 10.1212/01.WNL.0000289761.64862.ce
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre, Brain, vol.130, issue.5, pp.1235-1278, 2007. ,
DOI : 10.1093/brain/awm062
Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment. Mult Scler Houndmills Basingstoke Engl, pp.860-861, 2008. ,
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype, Neurology, vol.79, issue.12, 2012. ,
DOI : 10.1212/WNL.0b013e31826aac4e
Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen, Journal of the Neurological Sciences, vol.291, issue.1-2, pp.52-58, 2010. ,
DOI : 10.1016/j.jns.2010.01.002
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays, Neurology, vol.78, issue.9, 2012. ,
DOI : 10.1212/WNL.0b013e318248dec1
NMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICA, Neurology, vol.72, issue.12, pp.1101-1104, 2009. ,
DOI : 10.1212/01.wnl.0000345066.57745.50
Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status, Journal of the Neurological Sciences, vol.291, issue.1-2, pp.37-43, 2010. ,
DOI : 10.1016/j.jns.2010.01.009
Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica, Neurology, vol.62, issue.3, pp.476-484, 2004. ,
DOI : 10.1212/01.WNL.0000106946.08741.41
Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica, AJNR Am J Neuroradiol, vol.27, issue.5, pp.1009-1024, 2006. ,
URL : https://hal.archives-ouvertes.fr/inria-00123601
A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations, Multiple Sclerosis Journal, vol.27, issue.7, pp.1013-1034, 2011. ,
DOI : 10.1007/s00330-006-0175-8
Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica, Journal of Neurology, Neurosurgery & Psychiatry, vol.81, issue.4, pp.409-420, 2010. ,
DOI : 10.1136/jnnp.2008.168070
Cognitive Functions in Neuromyelitis Optica, Archives of Neurology, vol.65, issue.1, p.84, 2008. ,
DOI : 10.1001/archneurol.2007.16
White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica, PLoS ONE, vol.14, issue.4, p.33878, 2012. ,
DOI : 10.1371/journal.pone.0033878.t004
Cognitive impairment and cortical degeneration in neuromyelitis optica, Annals of Neurology, vol.122, issue.pt 7, p.2013 ,
DOI : 10.1002/ana.23721
Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study, European Journal of Radiology, vol.81, issue.2 ,
DOI : 10.1016/j.ejrad.2011.01.065
White matter volume is decreased in the brain of patients with neuromyelitis optica, European Journal of Neurology, vol.82, issue.2, pp.361-368, 2013. ,
DOI : 10.1111/j.1468-1331.2012.03867.x
Absence of cortical demyelination in neuromyelitis optica, Neurology, vol.75, issue.23, pp.2103-2112, 2010. ,
DOI : 10.1212/WNL.0b013e318200d80c
Inflammatory Cortical Demyelination in Early Multiple Sclerosis, New England Journal of Medicine, vol.365, issue.23, pp.2188-97, 2011. ,
DOI : 10.1056/NEJMoa1100648
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes, Proceedings of the National Academy of Sciences, vol.109, issue.4, pp.1245-50, 2012. ,
DOI : 10.1073/pnas.1109980108
Nosology of idiopathic transverse myelitis syndromes, Acta Neurologica Scandinavica, vol.64, issue.1, 2007. ,
DOI : 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
Long-term follow-up of acute partial transverse myelopathy, Neurology, vol.42, issue.1, pp.250-252, 1992. ,
DOI : 10.1212/WNL.42.1.250
Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis, European Journal of Neurology, vol.240, issue.1, pp.35-48, 1998. ,
DOI : 10.1097/00004728-199605000-00022
Evidence-based guideline: Clinical evaluation and treatment of transverse myelitis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, vol.77, issue.24, pp.2128-2162, 2011. ,
DOI : 10.1212/WNL.0b013e31823dc535
Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, pp.373-380, 2005. ,
Idiopathic inflammatory demyelinating disorders after acute transverse myelitis, European Journal of Neurology, vol.31, issue.8, pp.862-870, 2006. ,
DOI : 10.1159/000064490
Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings, Journal of the Neurological Sciences, vol.266, issue.1-2, pp.115-140, 2008. ,
DOI : 10.1016/j.jns.2007.09.010
Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features, Journal of Neurology, vol.7, issue.4, pp.488-92, 2007. ,
DOI : 10.1007/s00415-006-0400-z
Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey, Journal of the Neurological Sciences, vol.280, issue.1-2, pp.22-30, 2009. ,
DOI : 10.1016/j.jns.2009.01.008
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients, Multiple Sclerosis Journal, vol.20, issue.7, 2013. ,
DOI : 10.1177/1352458511431973
Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler Houndmills Basingstoke Engl, Feb, vol.1, issue.4, pp.218-240, 1996. ,
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study, BMC Neurology, vol.1, issue.2, p.33, 2013. ,
DOI : 10.1007/s00330-009-1425-3
Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica, Chin Med J (Engl, vol.125, issue.2, pp.270-274 ,
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients, Journal of Neuroinflammation, vol.76, issue.Pt 1, p.14, 2012. ,
DOI : 10.1186/1742-2094-9-14
Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan, Journal of the Neurological Sciences, vol.166, issue.1, pp.53-60, 1999. ,
DOI : 10.1016/S0022-510X(99)00115-X
Incident of intestinal parasitosis in Martinique]. Bull Société Pathol Exot Ses Fil, pp.406-422, 1983. ,
Prevalence of intestinal parasitism in the public laboratories of Martinique: development from, pp.169-71, 1988. ,
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization, International Immunology, vol.15, issue.1, pp.59-69, 2003. ,
DOI : 10.1093/intimm/dxg012
CD25+CD4+ Cells Contribute to Th2 Polarization during Helminth Infection by Suppressing Th1 Response Development, The Journal of Immunology, vol.173, issue.2, pp.1224-1255, 1950. ,
DOI : 10.4049/jimmunol.173.2.1224
'The marvellous harmony of the nervous parts': The origins of multiple sclerosis, Clinical Medicine, vol.4, issue.4, pp.346-54, 2004. ,
DOI : 10.7861/clinmedicine.4-4-346
Recurrent myelitis and optic neuritis in a 29-year-old woman, The Lancet Neurology, vol.4, issue.8, pp.510-516, 2005. ,
DOI : 10.1016/S1474-4422(05)70143-5
Complexity and heterogeneity in demyelinating disease, Brain, vol.130, issue.5, pp.1178-80, 2007. ,
DOI : 10.1093/brain/awm092
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution, Neurology, vol.80, issue.14, pp.1330-1337, 2013. ,
DOI : 10.1212/WNL.0b013e3182887957